Related Videos
Video
Corey Cutler, MD, MPH, on GVHD and Stem Cell Transplant
A Dana-Farber trial shows an antibody drug greatly reduces the risk of severe chronic #GVHD in patients undergoing allogenic stem cell transplant. Corey Cutler, MD, MPH, at #ASH23.